Core Viewpoint - China Tongyuan (01763) has successfully obtained a radiation safety license for its radiation source R&D and production base, marking a significant step in its capability to produce and sell radiation sources [1] Group 1: Project Approval and Capacity - The project is the largest radiation source R&D and production base in Asia, featuring 13 production lines for various radiation sources including Carbon-14 and Krypton-85 [1] - Upon completion, the annual production capacity will exceed 100,000 radiation sources [1] Group 2: Product Offering and Market Impact - The company will consolidate domestic resources for the R&D and production of radiation sources, offering over 70 types of high-quality radionuclide products to both domestic and international markets [1] - Services will include resource recycling and irradiation services, contributing positively to applications in industries such as agriculture, medicine, national defense, and aerospace [1] Group 3: Future Expansion Plans - China Tongyuan plans to promote the second phase of the project to further expand production capacity and diversify its product offerings [1] - New production lines for isotopes such as Californium-252, Cesium-137, and Americium-241 are planned to meet diverse market demands [1]